<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="159602">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01699594</url>
  </required_header>
  <id_info>
    <org_study_id>IIS-A-524</org_study_id>
    <secondary_id>BioReb #10-227</secondary_id>
    <nct_id>NCT01699594</nct_id>
  </id_info>
  <brief_title>Change in Airway Responsiveness After Allergen Exposure</brief_title>
  <official_title>Allergen Induced Increase in Indirect Non-allergic Bronchial Reactivity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Saskatchewan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Saskatchewan</source>
  <oversight_info>
    <authority>Canada: Health Canada</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Exposure to allergens changes the way the airway responds to some stimuli (methacholine).
      The investigators will look at whether or not exposure to allergens changes the way the
      airway responds to a different stimuli (mannitol) and compare that with the known stimuli
      (methacholine).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Change from baseline in airway responsiveness three hours after allergen exposure</measure>
    <time_frame>Change from Baseline at 3 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Allergic Asthma</condition>
  <arm_group>
    <arm_group_label>Mannitol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm will assess the allergen induced change in airway responsiveness to mannitol bronchoprovocation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Methacholine Chloride</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This arm will assess the allergen induced change in airway responsiveness to methacholine bronchoprovocation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mannitol</intervention_name>
    <description>Indirect bronchoprovocation agent being compared to direct bronchoprovocation agent (methacholine)</description>
    <arm_group_label>Mannitol</arm_group_label>
    <other_name>Aridol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methacholine Chloride</intervention_name>
    <description>Direct bronchoprovocation agent being compared to indirect bronchoprovocation agent (mannitol)</description>
    <arm_group_label>Methacholine Chloride</arm_group_label>
    <other_name>Provocholine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  mild, allergic asthma

          -  FEV1 greater than 70% predicted

          -  methacholine PC20 less than or equal to 16mg/ml

        Exclusion Criteria:

          -  known sensitivity to mannitol or other excipient

          -  diagnosis of any other respiratory or non respiratory disease/disorder that would
             preclude the individual from participating

          -  recent thoracic, abdominal or eye surgery

          -  recent allergen exposure (4 weeks), respiratory infection (6 weeks)

          -  current immunotherapy

          -  pregnancy

          -  history of anaphylaxis

          -  use of asthma therapies other than short acting beta agonist
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donald W Cockcroft, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Saskatchewan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Beth Davis, PhD.</last_name>
    <phone>306-966-8291</phone>
    <email>beth.davis@usask.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Saskatchewan</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <zip>S7N 0W8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Davis, PhD</last_name>
      <phone>306-966-8291</phone>
      <email>beth.davis@usask.ca</email>
    </contact>
    <contact_backup>
      <last_name>Beth</last_name>
    </contact_backup>
    <investigator>
      <last_name>Donald W Cockcroft, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Beth Davis, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>December 10, 2013</lastchanged_date>
  <firstreceived_date>October 1, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>asthma</keyword>
  <keyword>allergies</keyword>
  <keyword>mannitol</keyword>
  <keyword>methacholine</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Mannitol</mesh_term>
    <mesh_term>Methacholine Chloride</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
